On January 29, 2026, the Board of Directors of Bicycle Therapeutics plc appointed Travis Thompson as Chief Executive Officer. Travis brings extensive leadership experience in the biotechnology sector to this new role. His appointment marks a significant step in the company's growth strategy
Who to call at Bicycle Therapeutics, and when
A new leader at Bicycle Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Bicycle Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Bicycle Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Bicycle Therapeutics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Bicycle Therapeutics
About
Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company that is harnessing the power of bicyclic peptides and leveraging Nobel Prize-winning science to develop a new and differentiated class of medicines to treat cancer and other diseases. Bicycle® molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycle molecules attractive candidates for drug development.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Bicycle Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
